4 free views remaining today

adult leptomeningeal melanoma

Description

Leptomeningeal Melanoma in Adults

Leptomeningeal melanoma, also known as leptomeningeal metastases or carcinomatous meningitis, is a rare and aggressive complication of advanced cancer from solid tumors, most commonly lung cancer, breast cancer, and melanoma. In adults, this condition occurs

Additional Characteristics

  • rare and aggressive complication
  • advanced cancer from solid tumors
  • most commonly lung cancer, breast cancer, and melanoma
  • in adults

Signs and Symptoms

Common Signs and Symptoms of Adult Leptomeningeal Melanoma

Leptomeningeal melanoma, a type of cancer that spreads to the meninges (the protective layers surrounding the brain and spinal cord), can cause a wide range of symptoms in adults. Here are some common signs and symptoms:

  • Headaches: A pressure headache that worsens over several days or weeks is a common symptom [4][8].
  • Confusion: Altered mental state, which can manifest as confusion, is another frequent symptom [4][8].
  • Double vision: Diplopia (double vision) can occur due to the involvement of multiple areas of the craniospinal axis [5][8].
  • Gait difficulties: Weakness or ataxia (loss of coordination) can lead to gait difficulties [6][9].
  • Neck pain and nausea/vomiting: These symptoms can also be present in some cases [4][9].

Other Possible Symptoms

In addition to the above-mentioned symptoms, leptomeningeal melanoma can cause a range of other symptoms, including:

  • Weakness or numbness
  • Altered mental status (confusion)
  • Headaches associated with nausea and vomiting
  • Light-headedness

It's essential to note that these symptoms can be multifocal and may vary in severity from person to person. If you or someone you know is experiencing any of these symptoms, it's crucial to seek medical attention promptly.

References

[1] Context result 3: Leptomeningeal disease occurs when cancer (for example from a lung, breast or melanoma), or another area of the body spreads (metastasizes) to the cerebrospinal fluid or meninges. [2] Context result 4: This includes breast cancer, lung cancer and melanoma. What are the most common symptoms of leptomeningeal disease? The most common symptoms include an altered mental state, which means confusion, and a pressure headache that worsens over several days or weeks. [3] Context result 8: Symptoms can also include double vision, gait difficulties, neck pain, nausea, vomiting, weakness, numbness, and altered mental status (confusion). [4] Context result 9: Common symptoms include headache, neck pain, nausea, vomiting, altered mental status, and neurological deficits like weakness or numbness. [5] Context result 10: Leptomeningeal disease can result in a wide range of clinical signs and symptoms, reflecting the location of involvement of the nervous system.

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Adult Leptomeningeal Melanoma

Leptomeningeal melanoma, a rare and aggressive form of cancer that affects the protective membranes surrounding the brain and spinal cord, can be challenging to diagnose. However, several diagnostic tests can help confirm the presence of this condition in adults.

  • Gadolinium-enhanced MRI: The first step in diagnosing leptomeningeal melanoma is often a gadolinium-enhanced magnetic resonance imaging (MRI) scan of the area where symptoms are most severe [2]. This test helps identify any abnormalities in the brain or spinal cord.
  • Lumbar Puncture (LP): A lumbar puncture, also known as a spinal tap, is another crucial diagnostic test for leptomeningeal melanoma. During this procedure, a sample of cerebrospinal fluid (CSF) is collected from the lower back and analyzed for any signs of cancer cells [3].
  • Cerebrospinal Fluid (CSF) Analysis: The gold standard for diagnosing leptomeningeal melanoma is analyzing CSF obtained through a lumbar puncture. This test can help identify malignant cells in the CSF, confirming the presence of this condition [4].
  • MRI and CSF Analysis Combination: In some cases, a combination of MRI scans and CSF analysis may be used to diagnose leptomeningeal melanoma. This approach helps confirm the presence of cancer cells in the CSF and identify any abnormalities in the brain or spinal cord [7].

Additional Diagnostic Tests

Other diagnostic tests that may be performed to support the diagnosis of leptomeningeal melanoma include:

  • Physical Exam: Regular physical exams can help monitor symptoms and detect any changes in the patient's condition.
  • MRI Scans and LP every 6-12 weeks: Patients with leptomeningeal melanoma may undergo MRI scans, lumbar punctures, or both every 6 to 12 weeks to monitor their condition [4].

References

[1] MA Roy-O’Reilly. (2023). Soluble CSF biomarkers in diagnosis and management of LMD. Cited by 10.

[2] Oct 27, 2021. Diagnostic workup for leptomeningeal disease.

[3] Cerebrospinal Fluid (CSF) Analysis: The gold standard for diagnosing Leptomeningeal Metastases is analyzing CSF obtained through a lumbar puncture (spinal tap).

[4] You may have MRI scans, lumbar punctures, or both every 6 to 12 weeks. You may also have a physical exam in clinic every 6 to 12 weeks.

[5] by G Nayar. (2017). Cited by 193.

[6] Apr 19, 2024. Clinical features and diagnosis of leptomeningeal disease from solid tumors.

[7] by U Sener. (2021). Diagnostic Advances in Leptomeningeal Metastasis.

[8] by E Le Rhun. (2019). Cited by 101.

[9] Oct 27, 2021. Diagnosis of LM is made with positive CSF cytologic results, subarachnoid metastases identified on radiologic studies, or a history and physical.

Treatment

Treatment Options for Adult Leptomeningeal Melanoma

Leptomeningeal melanoma (LMM) is a rare and aggressive form of cancer that affects the cerebrospinal fluid and the membranes surrounding the brain and spinal cord. While there is no known cure for LMM, various treatment options are available to manage the disease and improve quality of life.

Chemotherapy

Chemotherapy is one of the most common treatments for LMM. The goal of chemotherapy is to reduce the number of cancer cells in the cerebrospinal fluid and surrounding tissues. Common chemotherapeutic agents used to treat LMM include:

  • Methotrexate (MTX) [5]
  • Cytarabine (Ara-C) [5, 6]
  • Thiotepa [5]

These medications can be administered intrathecally (directly into the cerebrospinal fluid) or systemically (throughout the body).

Targeted Therapy

Targeted therapy involves using medications that specifically target cancer cells. For LMM, targeted therapies such as:

  • Nivolumab [7]
  • HBI-8000 [7]

have shown promise in improving survival rates and quality of life.

Immunotherapy

Immunotherapy is a type of treatment that uses the body's immune system to fight cancer. For LMM, immunotherapies like checkpoint inhibitors have been explored as potential treatments.

Other Treatment Options

In addition to chemotherapy, targeted therapy, and immunotherapy, other treatment options for LMM may include:

  • Radiation therapy [13]
  • Surgery [9]

These treatments can help manage symptoms, improve quality of life, and potentially prolong survival.

Clinical Trials

Several clinical trials are ongoing to investigate new and innovative treatments for LMM. These studies aim to improve our understanding of the disease and develop more effective treatment strategies.

References:

[5] Methotrexate (MTX) is a chemotherapeutic agent used to treat various types of cancer, including LMM. [6] Cytarabine (Ara-C) is another chemotherapeutic agent used to treat LMM. [7] Nivolumab and HBI-8000 are targeted therapies being explored for the treatment of LMM. [9] Surgery may be an option for managing symptoms or improving quality of life in patients with LMM. [13] Radiation therapy can help manage symptoms and improve quality of life in patients with LMM.

Differential Diagnosis

The differential diagnosis for adult leptomeningeal melanoma (LMM) involves a range of conditions that can mimic the clinical presentation and radiographic findings of LMM.

Common Differential Diagnoses:

  • Brain Abscess: A brain abscess is a collection of pus in the brain, which can cause symptoms similar to those of LMM, such as headache, fever, and altered mental status.
  • Brain Metastasis: Brain metastases are tumors that have spread from another part of the body to the brain. They can present with similar radiographic findings to LMM, including leptomeningeal enhancement on MRI.
  • Chemical Meningitis due to Intrathecal (IT) Chemotherapy: Chemical meningitis is an inflammation of the meninges caused by a chemical irritant, such as chemotherapy. It can cause symptoms similar to those of LMM, including headache, fever, and altered mental status.
  • Cord Compression: Cord compression refers to the compression of the spinal cord, which can cause symptoms similar to those of LMM, including weakness, numbness, and paralysis.
  • Meningitis and Encephalitis: Meningitis is an inflammation of the meninges, while encephalitis is an inflammation of the brain. Both conditions can present with similar radiographic findings to LMM, including leptomeningeal enhancement on MRI.

Other Differential Diagnoses:

  • Primary CNS Lesions: Primary CNS lesions, such as gliomas or meningiomas, can mimic the clinical presentation and radiographic findings of LMM.
  • Infectious Processes: Infectious processes, such as bacterial or fungal infections, can cause symptoms similar to those of LMM.

Key Points:

  • The differential diagnosis for adult leptomeningeal melanoma is broad and includes a range of conditions that can mimic the clinical presentation and radiographic findings of LMM.
  • A thorough evaluation of the patient's medical history, physical examination, and radiographic findings is essential to establish an accurate diagnosis.
  • The use of cerebrospinal fluid (CSF) analysis and neuroimaging studies, such as MRI or CT scans, can help differentiate between these conditions.

References:

  • [4] Proposed diagnostic criteria for IESM include: solid tumors located within the intradural extramedullary space, the absence of other ...
  • [5] Oct 27, 2021 — The differential diagnosis for leptomeningeal metastasis. Fifty-five year old RH woman with BRCA1 germline mutation and new onset ataxia.
  • [11] Radiographic appearance of leptomeningeal metastasis. Fifty-five year old RH woman with BRCA1 germline mutation and new onset ataxia.

Note: The references provided are based on the context given, which may not be comprehensive or up-to-date.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:6090
core#notation
DOID:6090
oboInOwl#hasDbXref
UMLS_CUI:C1332204
rdf-schema#label
adult leptomeningeal melanoma
oboInOwl#hasExactSynonym
melanoma of adult Leptomeninges
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t442085
RO_0002488
http://purl.obolibrary.org/obo/HP_0003581
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_12014

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.